Basic Suprax Information

• INN (International Nonproprietary Name): Cefixime.
• Brand Names Available In Canada (English): Suprax (tablets 400 mg, oral suspension 100 mg/5 mL), generics marketed under cefixime.
• ATC Code: J01DD08.
• Forms & Dosages: Tablets 400 mg; Capsules 400 mg; Chewable tablets 100 mg and 200 mg; Oral suspension 100 mg/5 mL and 200 mg/5 mL.
• Manufacturers In Canada (English): Sanis Health Inc and other generic suppliers.
• Registration Status In Canada (English): Health Canada registrations listed by DINs 00868981 (400 mg tablet) and 00868965 (100 mg/5 mL suspension).
• OTC / Rx Classification: Prescription-only (Rx) in Canada.

Latest Research Highlights (Canadian & International, 2022–2025)

Patients and prescribers often ask whether cefixime still works for routine infections.

Available product data and guidance emphasise cefixime's role as a third‑generation cephalosporin reserved for susceptible bacterial infections.

Surveillance notes in public summaries underline the general risk of resistant pathogens and the need to avoid antibiotics for viral illnesses.

Specific Canadian and international trial details are not specified in the provided product data.

• Top Trial Takeaway 1: Stewardship remains central; use cefixime only for proven or strongly suspected bacterial infections.
• Top Trial Takeaway 2: Local susceptibility matters; check regional antibiograms before selecting cefixime for UTIs or respiratory infections.
• Top Trial Takeaway 3: Paediatric suspension dosing follows weight‑based recommendations where indicated; safety in under 6 months is not established.

Data highlights: cefixime is on the WHO Essential Medicines List, and product registries continue to track resistance and tolerability updates.

Clinical Effectiveness In Canada (Health Canada Monographs & DINs)

People want to know whether Suprax is effective for common infections seen in primary care.

Health Canada lists cefixime products with DINs 00868981 (400 mg tablet) and 00868965 (100 mg/5 mL suspension).

Canadian monographs classify cefixime as a third‑generation cephalosporin suitable where organisms are known or local resistance suggests benefit.

Typical primary care uses include uncomplicated urinary tract infections, otitis media, pharyngitis/tonsillitis, selected respiratory infections, and some single‑dose regimens for gonorrhoea in certain protocols.

Effectiveness depends on organism susceptibility and appropriate dosing for the indication.

Product — DIN — Common Indications

Suprax 400 mg tablet — 00868981 — uncomplicated UTI, otitis media, pharyngitis/tonsillitis, selected respiratory infections.

Suprax 100 mg/5 mL suspension — 00868965 — paediatric otitis media, pharyngitis where cefixime is indicated.

Provincial formularies may restrict routine use or require prior authorizations.

• Ontario Drug Benefit: coverage criteria vary; prior authorization may be required for some indications.
• BC PharmaCare: listings and special authority rules influence patient cost.
• RAMQ (Quebec): bilingual labelling expectations and formulary criteria apply.

Pharmacist counselling at retail chains improves adherence and supports safe use through clear dosing instructions and bilingual materials where required.

Indications & Expanded Uses (Approved Vs Off‑Label In Canadian Practice)

Patients often ask whether their infection is one that cefixime can treat.

Approved indications in Canada align with bacterial infections where oral third‑generation coverage is appropriate.

Common approved uses include uncomplicated UTI, otitis media, pharyngitis/tonsillitis, bronchitis of bacterial origin, and selected STI cases such as single 400 mg dosing for gonorrhoea in some protocols.

Off‑label uses occur when culture results support cefixime or as an oral step‑down after an IV cephalosporin in susceptible infections.

• Approved: Uncomplicated UTI, otitis media, pharyngitis/tonsillitis, selected respiratory infections, single‑dose gonorrhoea (where local guidance supports).
• Off‑Label: Targeted therapy for mixed infections when sensitivities favour cefixime; oral step‑down therapy after IV cephalosporin for susceptible organisms.

Cultural and logistic issues affect prescribing in Indigenous and remote communities, where local resistance patterns and supply chain limits guide empiric choices.

Stewardship remains essential; culture confirmation is recommended whenever possible.

Composition & Brand Landscape (Active Ingredient, Brands, Generics, DINs)

Many patients ask whether brand matters and how to recognise the right product at the pharmacy.

Active ingredient across brands is cefixime (INN).

In Canada, Suprax is available alongside generics, with the common forms being 400 mg tablets and 100 mg/5 mL suspension.

Manufacturers with product presence include Sanis Health Inc in Canada and Lupin Pharmaceuticals for Suprax in other markets.

International suppliers include Aurobindo, Cipla, Dr. Reddy’s, Egis, Krka, Teva and others; availability of specific packaging varies by market.

Patient counselling should include suspension reconstitution instructions and the need to refrigerate reconstituted suspension and discard after 14 days.

Contraindications & Special Precautions (Health Canada Advisories & High‑Risk Groups)

Common safety questions are about allergies, kidneys and pregnancy.

Absolute contraindications include known severe hypersensitivity to cefixime, other cephalosporins, or excipients.

A history of severe penicillin allergy should prompt careful review because of possible cross‑reactivity.

Precautions include renal impairment, where dosing must be adjusted.

• When To Avoid Or Modify Cefixime: Known severe cephalosporin allergy; creatinine clearance below thresholds requiring dose reduction; history of severe colitis or C. difficile; use in children under 6 months is not recommended.

Renal dosing guidance: reduce the dose by 50% if creatinine clearance is under 60 mL/min.

Pregnancy: cefixime is pregnancy category B and should be used only if clearly indicated.

High‑risk Canadian populations include the elderly, those with multiple comorbidities, and patients in remote or Indigenous communities who may have higher burdens of chronic disease.

Pharmacists should reconcile allergies and alert prescribers when penicillin allergy history is reported.

Dosage Guidelines (Standard Canadian Dosing & Renal Adjustments)

People commonly ask how much and how often to take Suprax.

Standard adult dosing for uncomplicated UTI is 400 mg once daily or 200 mg every 12 hours.

Many other adult indications use 400 mg once daily for 5–10 days unless otherwise directed.

Paediatric dosing for children aged 6 months to 12 years is 8 mg/kg once daily or 4 mg/kg every 12 hours, using available suspension strengths.

Reconstitution And Storage

Unreconstituted powder: store at room temperature.

Reconstituted suspension: refrigerate and discard after 14 days.

• Missed Dose: Take as soon as remembered unless the next dose is near; do not double up.
• Overdose: Provide supportive care and contact poison control or seek urgent medical attention.
• Pharmacist Counselling Checklist: Confirm indication, review allergies and renal function, instruct on reconstitution and storage, review duration and missed dose instructions.

Interactions Overview (Common Conflicts & Lifestyle Considerations)

Patients often worry whether cefixime will interact with their other medicines.

Cefixime has relatively few major drug interactions recorded in product data.

Concurrent use of nephrotoxic agents such as aminoglycosides or high‑dose NSAIDs warrants caution because cefixime is renally excreted.

Warfarin users should be monitored as changes in INR can occur with antibiotic exposure and intercurrent illness.

Alcohol does not have a direct interaction, but it can worsen gastrointestinal side effects and affect adherence.

Advise patients that severe diarrhoea may reduce oral contraceptive efficacy indirectly, so use backup contraception if diarrhoea is significant.

Cultural Perceptions & Patient Habits (Canada‑Centric Patient Feedback)

People want to know how other Canadians feel about Suprax and cefixime syrup.

Common patient concerns include cost, access, and palatability of paediatric suspension.

Patients in Quebec expect French counselling and bilingual labelling.

Remote and Indigenous communities emphasise culturally safe communication and reliable supply chains for medications.

• Patient Concern: Cost and formulary restrictions can delay access or require prior authorization.
• Patient Concern: Paediatric suspension taste affects adherence; pharmacists can suggest administration tips.
• Patient Concern: Rural patients may face limited formulation availability and longer delivery times.

Data highlight: pharmacies offering same‑day counselling and clear reconstitution instructions see higher adherence for paediatric suspensions.

Availability & Pricing Patterns (Chains, Online, Cross‑Border Notes)

Many Canadians ask where to buy Suprax and how much it costs.

Suprax and generic cefixime are available across major Canadian chains including Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs, with availability varying by location.

DINs 00868981 and 00868965 help confirm the exact product and support reimbursement claims.

Purchasing cautions: verify bilingual labelling for Quebec, confirm refrigeration guidance for reconstituted suspensions, and validate prescriptions for reimbursement.

Note on purchase context: in our online pharmacy, suprax is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Comparable Medicines And Preferences (Alternatives In Canada, Pros/Cons)

Clinicians and patients often ask whether another antibiotic would be better.

Alternatives in Canada include cefpodoxime, cefuroxime, cefdinir, and amoxicillin/clavulanate.

• When To Prefer Amoxicillin/Clavulanate: mixed aerobic/anaerobic infections or when broader beta‑lactam coverage is needed.
• When To Prefer Other Cephalosporins: based on susceptibility patterns, tolerability and formulary coverage.

Factors guiding choice include local antibiogram, renal function, allergy history, dosing convenience, and provincial coverage.

Pharmacists should map patient formulary coverage and discuss generic substitution when appropriate.

FAQ — Common Canadian Patient Questions

People usually bring a short list of practical questions to the pharmacy counter.

Q1: Can I buy Suprax without a prescription in Canada?

A1: Official product data classifies cefixime as prescription‑only, but individual pharmacy services vary; check requirements with your pharmacy and provincial rules.

Q2: Is Suprax safe for my child?

A2: Suspension is indicated for children aged 6 months and older with dosing of about 8 mg/kg once daily; reconstitute per label, refrigerate, and discard after 14 days.

Q3: Will cefixime affect my other medicines?

A3: Major interactions are few; monitor warfarin users and avoid co‑administration with other nephrotoxins when possible.

Q4: What if I miss a dose?

A4: Take the dose as soon as you remember unless the next dose is near; do not take a double dose.

Q5: Is it covered by my provincial plan?

A5: Coverage varies by province; check Ontario Drug Benefit, BC PharmaCare, or RAMQ for listing and prior authorization rules.

• What To Bring To The Pharmacy: valid prescription, list of current medications, allergy history, provincial health card.

Guidelines For Proper Use (Pharmacist & Provincial Tips)

Pharmacists should follow a short checklist when dispensing cefixime.

• Verify indication and ensure culture results are available where required.
• Review and document allergy history and reconcile penicillin or cephalosporin allergies.
• Check renal function and apply dosing reduction of approximately 50% if creatinine clearance is under 60 mL/min.
• Provide clear reconstitution and storage instructions for suspensions; advise refrigeration and 14‑day discard rule.
• Advise on common adverse effects and instruct patients to seek urgent care for anaphylaxis or severe colitis symptoms.

Emergency Signs Warranting Immediate Care

Anaphylaxis: difficulty breathing, swelling of face or throat, dizziness.

Severe Diarrhoea: persistent bloody stools or signs of C. difficile infection.

Provincial tips: document dispensing in provincial medication records when available, use bilingual counselling in Quebec, and plan supply logistics for remote communities where cold chain or timely delivery may be challenging.

Delivery Across Canada (English)